n vivo human studies indicated that patterns of 18F-AV1451 retention were paralleled with neuropathological staging of neurofibrillary tau pathology of AD and that tracer retention increased with age even in the presence of cognitive impairment and dementia (18, 20, 21). Here, MAPT is linked to Cognitive impairment.